On assessing the presence of evaluation-time bias in progression-free survival in randomized trials

被引:5
|
作者
Kay, Richard [1 ]
Wu, Jane [2 ]
Wittes, Janet [3 ]
机构
[1] RK Stat Ltd, Great Longstone, England
[2] Genta Inc, Berkeley Hts, NJ USA
[3] Stat Collaborat, Washington, DC USA
关键词
progression-free survival; simulation; logrank test;
D O I
10.1002/pst.443
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Evaluation (or assessment)-time bias can arise in oncology trials that study progression-free survival (PFS) when randomized groups have different patterns of timing of assessments. Modelling or computer simulation is sometimes used to explore the extent of such bias; valid results require building such simulations under realistic assumptions concerning the timing of assessments. This paper considers a trial that used a logrank test where computer simulations were based on unrealistic assumptions that severely overestimated the extent of potential bias. The paper shows that seemingly small differences in assumptions can lead to dramatic differences in the apparent operating characteristics of logrank tests. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 50 条
  • [41] Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis
    Bria, Emilio
    Massari, Francesco
    Maines, Francesca
    Pilotto, Sara
    Bonomi, Maria
    Porta, Camillo
    Bracarda, Sergio
    Heng, Daniel
    Santini, Daniele
    Sperduti, Isabella
    Giannarelli, Diana
    Cognetti, Francesco
    Tortora, Giampaolo
    Milella, Michele
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 93 (01) : 50 - 59
  • [42] The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation
    Tizianel, Irene
    Caccese, Mario
    Torresan, Francesca
    Lombardi, Giuseppe
    Evangelista, Laura
    Crimi, Filippo
    Sepulcri, Matteo
    Iacobone, Maurizio
    Padovan, Marta
    Galuppini, Francesca
    Zagonel, Vittorina
    Scaroni, Carla
    Ceccato, Filippo
    CANCERS, 2022, 14 (16)
  • [43] Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2- metastatic breast cancer
    Forsythe, Anna
    Chandiwana, David
    Barth, Janina
    Thabane, Marroon
    Baeck, Johan
    Tremblay, Gabriel
    BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 69 - 78
  • [44] Early stopping designs based on progression-free survival at an early time point in the initial cohort
    Litwin, Samuel
    Wong, Yu-Ning
    Hudes, Gary
    STATISTICS IN MEDICINE, 2007, 26 (24) : 4400 - 4415
  • [45] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [46] Evaluation of Three Definitions of Progression-free Survival in Preoperative Cancer Therapy (JCOG0801-A)
    Nakamura, Kenichi
    Shibata, Taro
    Takashima, Atsuo
    Yamamoto, Seiichiro
    Fukuda, Haruhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (10) : 896 - 902
  • [47] MRI radiomics predicts progression-free survival in prostate cancer
    Jia, Yushan
    Quan, Shuai
    Ren, Jialiang
    Wu, Hui
    Liu, Aishi
    Gao, Yang
    Hao, Fene
    Yang, Zhenxing
    Zhang, Tong
    Hu, He
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Progression-free survival as a surrogate endpoint in advanced neuroendocrine neoplasms
    Imaoka, Hiroshi
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Hashimoto, Yusuke
    Ohno, Izumi
    Mitsunaga, Shuichi
    Watanabe, Kazuo
    Umemoto, Kumiko
    Kimura, Gen
    Suzuki, Yuko
    Ikeda, Masafumi
    ENDOCRINE-RELATED CANCER, 2017, 24 (09) : 475 - 483
  • [49] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Lijun Zhang
    Chia-Wen Ko
    Shenghui Tang
    Rajeshwari Sridhara
    Therapeutic Innovation & Regulatory Science, 2013, 47 : 95 - 100
  • [50] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Zhang, Lijun
    Ko, Chia-Wen
    Tang, Shenghui
    Sridhara, Rajeshwari
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 95 - 100